Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use
Abstract is missing (Short communication)
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Society for Publication of Acta Dermato-Venereologica
2021-07-01
|
| Series: | Acta Dermato-Venereologica |
| Online Access: |
https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3848
|